Zepbound vs Wegovy: Which Weight Loss Medication Works Better?

Clinical Evidence

Zepbound vs Wegovy: Head-to-Head Weight-Loss Results

SURMOUNT-5 compared weekly tirzepatide and semaglutide injections over 72 weeks in adults with obesity without type 2 diabetes.

Average weight reduction: 20.2% vs 13.7%

Average body-weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide. The trial used maximum tolerated weekly doses of tirzepatide 10 or 15 mg and semaglutide 1.7 or 2.4 mg.

This open-label trial was funded by Lilly. These are group averages, not a prediction for you. The results do not compare oral Wegovy or every currently available injection dose. Side effects, medical history, coverage and long-term access also matter.

Treatment comparison

Zepbound contains tirzepatide and acts on GIP and GLP-1 receptors. Wegovy contains semaglutide and acts on GLP-1 receptors. Their milligram doses are not equivalent. Weekly injection comparisons should not be applied to daily oral Wegovy.

Head-to-head weight-loss evidence

The 2025 SURMOUNT-5 trial directly compared these injection regimens. Results should not be extrapolated to every dose, formulation, compounded product or person with diabetes.

Side effects and safety considerations

Both carry a boxed warning about thyroid C-cell tumors observed in rodents; the human relevance is unknown. They are contraindicated with a personal or family history of medullary thyroid carcinoma, MEN 2 or a serious allergy to the respective medicine. Severe gastroparesis, pregnancy plans, pancreatitis and gallbladder history require discussion.

Both can cause dehydration-related kidney injury and low blood sugar when used with insulin or sulfonylureas. Tell your anesthesia team before procedures because delayed stomach emptying may increase aspiration risk.

Seek urgent medical care for severe or persistent abdominal pain, repeated vomiting with inability to keep fluids down, fainting, or very little urine. Trouble breathing or swelling of the face or throat is an emergency. Severe bloating with vomiting or inability to pass stool or gas also needs urgent assessment.

How a clinician chooses between treatments

A clinician weighs your treatment goal, diabetes status, cardiovascular history, sleep apnea, kidney health, gastrointestinal tolerance, other medicines, pregnancy plans and access. A trial average cannot predict your individual response. Do not combine these medicines or switch doses yourself.

Ask your insurer about the exact brand and indication: formulary status, prior authorization, documented BMI and conditions, step therapy and renewal requirements can differ. Compare the total ongoing cost, including visits, labs, pharmacy charges and supplies; introductory prices and savings offers may change.

Dosing Depends on the Exact Product

Titration is gradual and depends on tolerance, indication and formulation. Zepbound weight-management maintenance doses are 5, 10 or 15 mg weekly. Wegovy injection usually uses 2.4 mg weekly maintenance; current labeling also lists Wegovy HD. Confirm the prescribed product and appropriate dose with your clinician.

Oral Wegovy follows a different schedule, starting at 1.5 mg daily for 30 days and escalating to 25 mg daily maintenance. Oral and injected doses are not interchangeable. Follow the full instructions for the exact prescription; do not use this comparison to switch or increase doses yourself.

How to Choose With Your Clinician

Greater average weight loss in a trial does not make one medication the right choice for everyone. Discuss your diagnoses, previous treatment response, side effects, pregnancy plans, other medicines and ability to continue treatment long term.

Both products carry boxed warnings about thyroid C-cell tumors and must not be used with a personal or family history of medullary thyroid carcinoma or MEN 2. Discuss severe digestive symptoms, dehydration, pancreatitis or gallbladder concerns with your clinician. Read the full medication guide for your prescribed product.

• Ask which approved indication and formulation fit your health history.
• Check coverage for the exact brand and formulation, prior authorization, deductible and ongoing out-of-pocket cost.
• Ask what follow-up, symptom support and maintenance planning will involve.
• If changing treatment, request a clinician-directed plan rather than converting doses yourself.

What to Prepare Before Your Weight-Loss Assessment

Have your height, current weight, health conditions, medication and supplement list, previous weight-loss treatments, allergies and insurance details ready. Confirm service availability in your state and the exact medication options offered.

An assessment helps a clinician review suitability. It does not guarantee a prescription, a particular brand, insurance approval or a specific weight-loss result. Confirm consultation, medication, laboratory and follow-up charges before starting.

What to discuss with your clinician

• Your diagnosis, treatment goals and medical history.
• The exact product, dose, safety precautions and ongoing cost.
• Your follow-up plan and symptoms that need prompt assessment.

Frequently asked questions